Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

NCT00101894 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Cancer
Colon Cancer

Interventions

DRUG: FOLFOX-4
DRUG: AMG 706
BIOLOGICAL: Panitumumab (Part 1a only)
DRUG: FOLFIRI

Sponsor

Amgen